Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice.
about
Microbial translocation in chronic liver diseasesGut microbiota and metabolic syndromeNon-Alcoholic Fatty Liver Disease and Extra-Hepatic CancersGut Microbiota and Lifestyle Interventions in NAFLDDiet, Microbiota, Obesity, and NAFLD: A Dangerous QuartetInvolvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesitySimple sugar intake and hepatocellular carcinoma: epidemiological and mechanistic insightCarbohydrate intake and nonalcoholic fatty liver disease: fructose as a weapon of mass destructionEnergy metabolism in the liverIntestinal permeability--a new target for disease prevention and therapySchisandrin B: A Double-Edged Sword in Nonalcoholic Fatty Liver DiseaseVitamin D: a new player in non-alcoholic fatty liver disease?How Inflammation Impinges on NAFLD: A Role for Kupffer CellsGut microbiota, intestinal permeability, obesity-induced inflammation, and liver injuryNon-alcoholic fatty liver disease: need for a balanced nutritional sourceReactive oxygen species-induced TXNIP drives fructose-mediated hepatic inflammation and lipid accumulation through NLRP3 inflammasome activationSusceptibility of Different Mouse Wild Type Strains to Develop Diet-Induced NAFLD/AFLD-Associated Liver DiseaseIn vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD).High Dietary Fructose: Direct or Indirect Dangerous Factors Disturbing Tissue and Organ FunctionsThe Angiogenesis Inhibitor ALS-L1023 from Lemon-Balm Leaves Attenuates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease through Regulating the Visceral Adipose-Tissue Function.Macrophages and fibrosis in adipose tissue are linked to liver damage and metabolic risk in obese children.Western diet enhances hepatic inflammation in mice exposed to cecal ligation and punctureEvolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation.Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver diseaseGut microbiota, probiotics and diabetes.Chronic Fructose Ingestion as a Major Health Concern: Is a Sedentary Lifestyle Making It Worse? A Review.Toll-like receptor 4 and hepatic fibrogenesisReactive oxygen and nitrogen species in steatotic hepatocytes: a molecular perspective on the pathophysiology of ischemia-reperfusion injury in the fatty liver.High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis.Fructose and cardiometabolic disorders: the controversy will, and must, continue.Contribution of gut bacteria to liver pathobiology.Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver diseaseTLR4 and Insulin Resistance.Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded?Comparison with ancestral diets suggests dense acellular carbohydrates promote an inflammatory microbiota, and may be the primary dietary cause of leptin resistance and obesityToll-like receptor 4 signaling in liver injury and hepatic fibrogenesis.Fructose induced endotoxemia in pediatric nonalcoholic Fatty liver disease.JNK regulation of hepatic manifestations of the metabolic syndrome.Fructose, pregnancy and later life impacts.Recent advances in the development of farnesoid X receptor agonists
P2860
Q21284997-B30D2C01-9F9D-4390-B643-B0CFE055B060Q24563886-7DA5B428-D5FB-4839-B795-E9E80D5BA796Q26749045-EC378DF8-7B97-4F55-B43B-C7233732B2C6Q26749783-F71D02B1-5E90-4889-BB8C-EC6D81BD6421Q26752614-DAE5A1F6-29F9-4600-AA0F-BC1602805DD8Q26828547-6DC4A15C-881A-4CCB-8EDD-629EADAA22F9Q26864513-1897F572-DCCB-43C5-BC03-0B5CECA041ABQ26991952-85825F8B-D59B-4F6C-A71D-E74E2778F6E5Q26996783-1C14CE85-564B-4E03-9C5E-370FCC8BEBFFQ27015884-48B6B454-6604-4765-AB03-2385D0ED0B67Q28078342-8E55B771-38C4-4088-AD0E-FEE1CEEC2E1DQ28081391-7BAC76CD-BF06-49BC-9C52-89E65F60CB35Q28083001-01D4EF61-B0DF-4760-8336-8DE6418B2681Q28244656-B79DB3AB-411E-4D9A-B982-96E0FB54E258Q28248994-3E66D172-D990-4468-A956-B3525A2D7DABQ28390197-7472DEE4-29DD-4320-947F-69878D9E04ABQ28551941-949139B2-6523-4F3B-B851-8E74ED3B06D6Q30452333-9635B672-6B7D-4E03-BF3A-74378A7A2CA8Q33616618-3612117D-37A9-4A2C-86D3-62FA17D3AC36Q33624836-1C80C232-7D12-418C-8166-C018568E9746Q33680347-BA0E8D4D-16C5-4777-89A2-3AB85331E1E5Q33722712-57E52FF5-DDC8-4DF0-8389-A525047056D3Q33755829-A91F269B-4A05-4AE7-81D4-D6C8EDD79D71Q33780172-5CAC0891-E289-40B6-BC28-B00A7F6BE9C4Q33831849-C9A0E923-C6D9-4872-95F3-43D7CB84EDD5Q33851818-BF875616-A60C-40FE-89E4-F99CEB708515Q33905721-26CD2847-D344-46AB-A043-E795E515437CQ34009236-C1F01563-1E6B-4F6B-B0EB-F97DEDC919A2Q34023013-4504AAAA-8DE9-42C8-81C8-4C1208DA6600Q34023494-EF49C1E4-5128-4901-B787-0F6361706654Q34035372-889A443B-B834-4536-8A9D-5178E54306EBQ34069352-63DD4677-62EB-4BB7-B067-AA0C2A7D8003Q34097407-BDFB41FD-3342-4EC1-B055-0743CCE9745FQ34153569-16FAC4D2-FD2E-45DC-8FB8-29B301069A28Q34289971-5158BADB-1E3B-4E50-8BD2-97E180E5361DQ34321742-1492AF99-E5AD-475B-96B2-0BC330FE7B40Q34330120-7C145E3B-8C0D-402D-942F-BE53F29702F6Q34348797-C63E5B66-507B-498A-A1E0-CC5E56598A27Q34370884-0A4A9B5E-771C-4551-9514-A178D741AC11Q34464043-CA1D6E10-3E8D-44D3-A39F-3EFB525BB170
P2860
Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Toll-like receptor 4 is involv ...... ced hepatic steatosis in mice.
@en
Toll-like receptor 4 is involv ...... ced hepatic steatosis in mice.
@nl
type
label
Toll-like receptor 4 is involv ...... ced hepatic steatosis in mice.
@en
Toll-like receptor 4 is involv ...... ced hepatic steatosis in mice.
@nl
prefLabel
Toll-like receptor 4 is involv ...... ced hepatic steatosis in mice.
@en
Toll-like receptor 4 is involv ...... ced hepatic steatosis in mice.
@nl
P2093
P356
P1433
P1476
Toll-like receptor 4 is involv ...... ced hepatic steatosis in mice.
@en
P2093
Astrid Spruss
Giridhar Kanuri
Ina Bergheim
Sabine Wagnerberger
Stephan C Bischoff
Synia Haub
P304
P356
10.1002/HEP.23122
P407
P577
2009-10-01T00:00:00Z